Key statistics
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 31.40 |
---|---|
High | 31.40 |
Low | 31.20 |
Bid | 31.00 |
Offer | 31.60 |
Previous close | 31.40 |
Average volume | 46.00 |
---|---|
Shares outstanding | 76.81m |
Free float | 76.18m |
P/E (TTM) | -- |
Market cap | 2.68bn USD |
EPS (TTM) | -0.7444 USD |
Data delayed at least 15 minutes, as of Sep 20 2024.
More ▼
Press releases
- New Data Presented at ESMO 2024 Show that Veracyte’s Decipher Prostate Test Predicts Chemotherapy Benefit in Patients with Metastatic Prostate Cancer
- Veracyte Appoints Brent Shafer and Tom Miller, Ph.D., to Its Board of Directors
- Veracyte to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
- Veracyte Named a Greater Bay Area Top Workplace by the San Francisco Chronicle
- Veracyte Announces Second Quarter 2024 Financial Results
- Veracyte to Release Second Quarter 2024 Financial Results on August 6, 2024
More ▼